The Resilience of Attitude Toward Vaccination: Web-Based Randomized Controlled Trial on the Processing of Misinformation.

Autor: Béchard B; School of Psychology, Université Laval, Québec, QC, Canada., Gramaccia JA; Department of Communication, University of Ottawa, Ottawa, ON, Canada., Gagnon D; Quebec National Institute of Public Health, Québec, QC, Canada., Laouan-Sidi EA; Quebec National Institute of Public Health, Québec, QC, Canada., Dubé È; Department of Anthropology, Université Laval, Québec, QC, Canada., Ouimet M; Department of Political Science, Université Laval, Québec, QC, Canada., de Hemptinne D; School of Psychology, Université Laval, Québec, QC, Canada., Tremblay S; School of Psychology, Université Laval, Québec, QC, Canada.

Publikováno v: JMIR formative research [JMIR Form Res] 2024 Dec 04; Vol. 8, pp. e52871. Date of Electronic Publication: 2024 Dec 04.

Trends in COPD severe exacerbations, and all-cause and respiratory mortality, before and after implementation of newer long-acting bronchodilators in a large population-based cohort.

Autor: Guay CA; Centre de Recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, 2725, chemin Sainte-Foy, Québec, QC, G1V 4G5, Canada. charles-antoine.guay.1@ulaval.ca.; Institut national de santé publique du Québec, Québec City, Canada. charles-antoine.guay.1@ulaval.ca.; Département des sciences de la santé communautaire, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Canada. charles-antoine.guay.1@ulaval.ca.; Department of Medicine, Université Laval, Québec City, Canada. charles-antoine.guay.1@ulaval.ca., Maltais F; Centre de Recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, 2725, chemin Sainte-Foy, Québec, QC, G1V 4G5, Canada.; Department of Medicine, Université Laval, Québec City, Canada., Beaudoin C; Institut national de santé publique du Québec, Québec City, Canada., Carmichael PH; Centre d'excellence sur le vieillissement de Québec, Québec, Canada., Laouan Sidi EA; Institut national de santé publique du Québec, Québec City, Canada., Perreault L; Centre de Recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, 2725, chemin Sainte-Foy, Québec, QC, G1V 4G5, Canada., Sirois C; Institut national de santé publique du Québec, Québec City, Canada.; Centre d'excellence sur le vieillissement de Québec, Québec, Canada.; Faculty of pharmacy, Université Laval, Québec City, Canada., Provencher S; Centre de Recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, 2725, chemin Sainte-Foy, Québec, QC, G1V 4G5, Canada.; Department of Medicine, Université Laval, Québec City, Canada.

Publikováno v: BMC pulmonary medicine [BMC Pulm Med] 2024 Sep 13; Vol. 24 (1), pp. 450. Date of Electronic Publication: 2024 Sep 13.

Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec's health services register cohort.

Autor: Lunghi C; Department of Health Sciences, Université du Québec à Rimouski, Lévis, QC, Canada.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Institut National de Santé Publique du Québec, Quebec, QC, Canada., Cailhol L; Department of Psychiatry and Research Center, Institut Universitaire de Santé Mentale de Montréal, Montreal, QC, Canada.; Department of Psychiatry and Addiction, Université de Montréal, Montreal, QC, Canada., Massamba V; Institut National de Santé Publique du Québec, Quebec, QC, Canada., Laouan Sidi EA; Institut National de Santé Publique du Québec, Quebec, QC, Canada., Sirois C; Institut National de Santé Publique du Québec, Quebec, QC, Canada.; Faculty of Pharmacy, Université Laval, Quebec, QC, Canada., Rahme E; Division of Clinical Epidemiology, Department of Medicine, McGill University, Montreal, QC, Canada., Rochette L; Institut National de Santé Publique du Québec, Quebec, QC, Canada., Renaud S; Department of Psychiatry and Addiction, Université de Montréal, Montreal, QC, Canada.; CISSS des Laurentides et CISSS des Iles, Saint-Jérôme, QC, Canada., Villeneuve E; Faculty of Medicine, Université Laval, Quebec, QC, Canada.; Institut universitaire en santé mentale de Québec, Quebec, QC, Canada., Koch M; Department of Psychiatry, McGill University, Montreal, QC, Canada.; Department of Psychiatry, Hôpital de Gatineau, Gatineau, QC, Canada., Biskin R; Department of Psychiatry, McGill University, Montreal, QC, Canada., Martineau C; Department of Health Sciences, Université du Québec à Rimouski, Lévis, QC, Canada., Vincent P; Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada., David P; Department of Psychiatry and Research Center, Institut Universitaire de Santé Mentale de Montréal, Montreal, QC, Canada.; Department of Psychiatry and Addiction, Université de Montréal, Montreal, QC, Canada., Lesage A; Institut National de Santé Publique du Québec, Quebec, QC, Canada.; Department of Psychiatry and Research Center, Institut Universitaire de Santé Mentale de Montréal, Montreal, QC, Canada.; Department of Psychiatry and Addiction, Université de Montréal, Montreal, QC, Canada.

Publikováno v: Frontiers in psychiatry [Front Psychiatry] 2023 Nov 23; Vol. 14, pp. 1243511. Date of Electronic Publication: 2023 Nov 23 (Print Publication: 2023).

Exposure to ultrafine particles and the incidence of asthma in children: A population-based cohort study in Montreal, Canada.

Autor: da Silveira Fleck A; Department of Environmental and Occupational Health, School of Public Health, University of Montreal, Montreal, Canada., Vachon J; Department of Environmental and Occupational Health, School of Public Health, University of Montreal, Montreal, Canada.; Center for Public Health Research (CReSP), University of Montreal and CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montreal, Canada., Buteau S; Department of Environmental and Occupational Health, School of Public Health, University of Montreal, Montreal, Canada.; Institut national de santé publique du Québec (INSPQ), Montreal, Canada., Laouan-Sidi EA; Institut national de santé publique du Québec (INSPQ), Montreal, Canada., Hatzopoulou M; Department of Civil Engineering, University of Toronto, Toronto, Canada., Weichenthal S; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada., Smargiassi A; Department of Environmental and Occupational Health, School of Public Health, University of Montreal, Montreal, Canada.; Center for Public Health Research (CReSP), University of Montreal and CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montreal, Canada.; Institut national de santé publique du Québec (INSPQ), Montreal, Canada.

Publikováno v: Environmental epidemiology (Philadelphia, Pa.) [Environ Epidemiol] 2022 Dec 14; Vol. 7 (1), pp. e236. Date of Electronic Publication: 2022 Dec 14 (Print Publication: 2023).

Long-term exposure to fine particulate matter and ozone and the onset of systemic autoimmune rheumatic diseases: an open cohort study in Quebec, Canada.

Autor: Zhao N; Division of Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada., Smargiassi A; Département de Santé Environnementale Et de Santé Au Travail, School of Public Health, Université de Montréal, Montréal, QC, Canada.; Institut National de Santé Publique du Québec, Montréal, QC, Canada.; Centre of Public Health Research, University of Montreal and CIUSSS du Centre-Sud-de-L'Île-de-Montréal, Montreal, Canada., Jean S; Centre of Public Health Research, University of Montreal and CIUSSS du Centre-Sud-de-L'Île-de-Montréal, Montreal, Canada.; Université Laval and Bureau d'information Et d'études en Santé Des Populations, Institut National de Santé Publique du Québec (INSPQ), 945, avenue Wolfe, Québec, QC, G1V 5B3, Canada., Gamache P; Centre of Public Health Research, University of Montreal and CIUSSS du Centre-Sud-de-L'Île-de-Montréal, Montreal, Canada., Laouan-Sidi EA; Centre of Public Health Research, University of Montreal and CIUSSS du Centre-Sud-de-L'Île-de-Montréal, Montreal, Canada., Chen H; Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.; Public Health Ontario, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Goldberg MS; Division of Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada.; Department of Medicine, McGill University, Québec, Canada., Bernatsky S; Division of Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada. sasha.bernatsky@mcgill.ca.; Department of Medicine, McGill University, Québec, Canada. sasha.bernatsky@mcgill.ca.; Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada. sasha.bernatsky@mcgill.ca.; Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, 5252 Boul. de Maisonneuve Ouest, (3F.51), Montreal, QC, H4A 3S5, Canada. sasha.bernatsky@mcgill.ca.

Publikováno v: Arthritis research & therapy [Arthritis Res Ther] 2022 Jun 23; Vol. 24 (1), pp. 151. Date of Electronic Publication: 2022 Jun 23.